




Searching News Database: Santarus
HSMN NewsFeed - 3 May 2016
Patara Pharma Appoints Biotechnology Industry Leader John Schmid to Board of Directors
Patara Pharma Appoints Biotechnology Industry Leader John Schmid to Board of Directors
HSMN NewsFeed - 25 Aug 2015
Regulus Appoints Michael Huang, M.D. as Vice President, Clinical Development
Regulus Appoints Michael Huang, M.D. as Vice President, Clinical Development
HSMN NewsFeed - 26 Aug 2014
Adamis Pharmaceuticals Announces Appointment of New Members to Its Board of Directors
Adamis Pharmaceuticals Announces Appointment of New Members to Its Board of Directors
HSMN NewsFeed - 6 Sep 2013
Oncothyreon Announces Appointment of Ted W. Love, M.D. to Board of Directors
Oncothyreon Announces Appointment of Ted W. Love, M.D. to Board of Directors
HSMN NewsFeed - 14 Feb 2013
Santarus Announces Commercial Launch of UCERIS (budesonide) Extended Release Tablets
Santarus Announces Commercial Launch of UCERIS (budesonide) Extended Release Tablets
HSMN NewsFeed - 10 Apr 2012
Santarus Appoints Alessandro E. Della Chà and Matthew W. Strobeck to Board of Directors
Santarus Appoints Alessandro E. Della Chà and Matthew W. Strobeck to Board of Directors
HSMN NewsFeed - 28 Dec 2010
Pharming and Santarus announce submission of Rhucin Biologics License Application to FDA
Pharming and Santarus announce submission of Rhucin Biologics License Application to FDA
HSMN NewsFeed - 15 Nov 2010
Santarus Announces Commercial Launch of Novel Type 2 Diabetes Drug CYCLOSET
Santarus Announces Commercial Launch of Novel Type 2 Diabetes Drug CYCLOSET
HSMN NewsFeed - 5 Oct 2010
RHUCIN Clinical Trial Data Published in the Journal of Allergy and Clinical Immunology
RHUCIN Clinical Trial Data Published in the Journal of Allergy and Clinical Immunology
HSMN NewsFeed - 13 Sep 2010
Pharming signs commercialization agreement with Santarus for Rhucin(R) in North America
Pharming signs commercialization agreement with Santarus for Rhucin(R) in North America
HSMN NewsFeed - 25 Mar 2010
Santarus Announces Completion of Enrollment in U.S. Phase III Clinical Study for Budesonide MMX
Santarus Announces Completion of Enrollment in U.S. Phase III Clinical Study for Budesonide MMX
HSMN NewsFeed - 1 Dec 2009
FDA Approves ZEGERID OTC(TM) for Over-the-Counter Treatment of Frequent Heartburn
FDA Approves ZEGERID OTC(TM) for Over-the-Counter Treatment of Frequent Heartburn
HSMN NewsFeed - 10 Nov 2009
Depomed Receives Notice of Paragraph IV Certification Against Patents for GLUMETZA(R)
Depomed Receives Notice of Paragraph IV Certification Against Patents for GLUMETZA(R)
HSMN NewsFeed - 22 Jul 2008
Santarus and Depomed Announce U.S. Promotion Agreement for GLUMETZA Prescription Products
Santarus and Depomed Announce U.S. Promotion Agreement for GLUMETZA Prescription Products
HSMN NewsFeed - 28 May 2008
Santarus Announces Development Program for New ZEGERID Prescription Product
Santarus Announces Development Program for New ZEGERID Prescription Product
HSMN NewsFeed - 15 Apr 2008
Santarus Provides Termination Notice to Otsuka America Pharmaceutical for ZEGERID Co-Promotion Agreement
Santarus Provides Termination Notice to Otsuka America Pharmaceutical for ZEGERID Co-Promotion Agreement
HSMN NewsFeed - 11 Mar 2008
Santarus Announces Submission of New Drug Application by Schering-Plough for ZEGERID Branded OTC Product
Santarus Announces Submission of New Drug Application by Schering-Plough for ZEGERID Branded OTC Product
HSMN NewsFeed - 19 Feb 2008
Santarus Announces Launch of ZEGERID Products by GlaxoSmithKline in Puerto Rico and U.S. Virgin Islands
Santarus Announces Launch of ZEGERID Products by GlaxoSmithKline in Puerto Rico and U.S. Virgin Islands
HSMN NewsFeed - 27 Aug 2007
Santarus Announces Co-Promotion Agreement for Fleet Phospho-soda EZ-Prep System
Santarus Announces Co-Promotion Agreement for Fleet Phospho-soda EZ-Prep System
HSMN NewsFeed - 7 Aug 2007
Santarus Receives Notice of Paragraph IV Certification Against Patents for ZEGERID Capsules
Santarus Receives Notice of Paragraph IV Certification Against Patents for ZEGERID Capsules
HSMN NewsFeed - 2 Feb 2007
Schering-Plough Cites Today's Anacor Agreement as Latest in Series of Deals
Schering-Plough Cites Today's Anacor Agreement as Latest in Series of Deals
HSMN NewsFeed - 21 Nov 2006
Santarus Announces Effective Date of OTC License Agreement with Schering-Plough
Santarus Announces Effective Date of OTC License Agreement with Schering-Plough
HSMN NewsFeed - 3 Nov 2006
Santarus and inVentiv Health Announce Agreement to Add Representatives to Santarus' ZEGERID Sales Team
Santarus and inVentiv Health Announce Agreement to Add Representatives to Santarus' ZEGERID Sales Team
HSMN NewsFeed - 18 Oct 2006
Santarus Licenses OTC Rights to Lower Dosage Immediate-Release ZEGERID Products to Schering-Plough
Santarus Licenses OTC Rights to Lower Dosage Immediate-Release ZEGERID Products to Schering-Plough
Additional items found! 25

Members Archive contains
25 additional stories matching:
Santarus
(Password required)
Santarus
(Password required)